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ABSTRACT
Ets homologous factor (EHF) is an Ets family tran-
scription factor expressed in many epithelial cell
types including those lining the respiratory system.
Disruption of the airway epithelium is central to many
lung diseases, and a network of transcription factors
coordinates its normal function. EHF can act as a
transcriptional activator or a repressor, though its
targets in lung epithelial cells are largely uncharac-
terized. Chromatin immunoprecipitation followed by
deep sequencing (ChIP-seq), showed that the major-
ity of EHF binding sites in lung epithelial cells are
intergenic or intronic and coincide with putative en-
hancers, marked by specific histone modifications.
EHF occupies many genomic sites that are close to
genes involved in intercellular and cell–matrix adhe-
sion. RNA-seq after EHF depletion or overexpression
showed significant alterations in the expression of
genes involved in response to wounding. EHF knock-
down also targeted genes in pathways of epithe-
lial development and differentiation and locomotory
behavior. These changes in gene expression coin-
cided with alterations in cellular phenotype includ-
ing slowed wound closure and increased transep-
ithelial resistance. Our data suggest that EHF regu-
lates gene pathways critical for epithelial response
to injury, including those involved in maintenance of
barrier function, inflammation and efficient wound
repair.
INTRODUCTION
The surface of the trachea and bronchial tree is covered with
an epithelial layer that is critical for establishing and main-
taining normal lung function. Not only does the epithelium
provide a physical barrier between the outside environment
and other tissues within the lung, it also makes a major con-
tribution to the production and homeostasis of airway sur-
face liquid (ASL), which is pivotal to a healthy respiratory
environment (1). The structural integrity of the lung epithe-
lium is maintained by intercellular tight junctions, and by
additional mechanisms that adhere the epithelial cells to
each other and to the underlying basement membrane (2).
Under normal conditions, the epithelial cells play an impor-
tant role in defense against external insults by driving the
mucociliary escalator, which removes foreign particles and
pathogens from the lung (3,4). Epithelial dysfunction un-
derlies the pathology of several human respiratory diseases,
including cystic fibrosis (CF), asthma and chronic obstruc-
tive pulmonary disease (COPD) (5–7). A significant compo-
nent of dysfunction in these diseases is associated with im-
paired epithelial repair, inflammation and fibrosis (8). Ep-
ithelial cell function is regulated by networks of transcrip-
tion factors that control gene expression (9–11) and show
some common features across all epithelia in addition to
organ-specific programs. The application of genome-wide
approaches to study the critical transcription factors in lung
epithelial differentiation is beginning to elucidate the molec-
ular basis of these pathways.
Ets homologous factor (EHF) is a member of the
epithelial-specific Ets transcription factor subfamily that is
expressed in multiple epithelial cell types, including those in
the lung (12–14). EHF has been shown to act at the pro-
moter of genes to either activate or repress transcription
(12,15,16). Moreover, predicted EHF binding sites are over-
represented in intergenic open chromatin genome-wide in
primary human tracheal and bronchial epithelial cells (9),
suggesting that this factor plays an important role in the
transcriptional program of these cells. EHF contributes to
corneal epithelial cell fate (17), and in prostate cancer cells,
loss of EHF promotes epithelial to mesenchymal transi-
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tion (EMT) (18). During EMT, epithelial cells transition to
a more mesenchymal phenotype, losing intercellular junc-
tions and in some circumstances becoming more motile
(19). Similar pathways are likely to be involved in lung ep-
ithelial repair after injury, and an exaggerated response may
be associated with lung fibrosis, a prominent feature of mul-
tiple airway diseases (20,21).
Also relevant to inflammatory diseases of the airway is
the regulation of EHF by cytokines in bronchial epithelial
cells, where interleukin-1 (IL-1) and/or tumor necrosis
factor- (TNF-) increase EHF expression in an NF-B
dependent manner (22). Renewed interest in the potential
importance of EHF in lung disease arose from a genome-
wide association study (GWAS) to identify genetic mark-
ers of lung disease severity in the inherited disorder CF
(23). Single nucleotide polymorphisms (SNPs) showing the
strongest association with this trait mapped to an intergenic
region of chromosome 11p13. The EHF gene maps imme-
diately adjacent to this region on the 5’ side and so became
a candidate factor for an important role in lung epithelial
function in health and disease. However, to date very little
is known about the biological targets of EHF in airway ep-
ithelial cells and thus is the focus of this study. We hypoth-
esize that through its direct interaction with cis-regulatory
elements of critical genes, EHF controls essential cellular
processes that coordinate the barrier function of the lung
epithelium and participate in wound repair mechanisms.
We used Calu-3 lung adenocarcinoma cells for this anal-
ysis since they are highly differentiated and express criti-
cal markers of normal human airway epithelial function.
Specifically, they form polarized monolayers in culture with
tight junctions that lead to high transepithelial resistance,
and they respond to cAMP agonists that drive chloride se-
cretion across the epithelial layer (24). These properties of
Calu-3 cells replicate key features of the normal lung epithe-
lium.
Here, we show that EHF regulates genes that are im-
portant for normal epithelial function. Using chromatin
immunoprecipitation followed by deep sequencing (ChIP-
seq) and RNA-sequencing (RNA-seq) after modulation of
EHF levels, we identify a genome-wide binding signature
for EHF and also determine its transcriptional targets. We
also find that changes in gene expression correlate with phe-
notypic changes in airway epithelial cell behavior. In EHF-
depleted lung adenocarcinoma cells, wound repair is de-
layed and transepithelial resistance (TER) is increased, sug-
gesting that EHF is critical for maintenance of a differenti-
ated phenotype in the airway epithelium.
MATERIALS AND METHODS
Cell culture
Calu-3 and A549 cells were obtained from ATCC and cul-
tured by standard methods. A549 stable clones overexpress-
ing EHF from pcDNA-EHF or control clones carrying
pcDNA3.1 were generated by Lipofectin (Life Technologies
(LT)) transfection, followed by G418 selection.
Western blots
Calu-3 cell lysates were analysed by standard methods. An-
tibodies used were specific for EHF (Clone 5A.5, Pierce),
ITGA2 (ab133557, Abcam) and -tubulin (T4026, Sigma-
Aldrich).
ChIP-seq
The antibodies used for ChIP-seq were for EHF (Clone
5A.5), H3K4me1 (ab8895, Abcam) and H3K27ac (ab4729,
Abcam). ChIP-seq was performed as described previously
(25–27) with some modifications (see supplementary meth-
ods). Sequence data are summarized in Supplementary Ta-
ble S1. Binding sites were identified using HOMER soft-
ware (28). Two replicates of EHF ChIP-seq were performed.
Peaks that were identified in both replicates were used for
further analysis. To confirm results, ChIP was performed
as described, followed by qPCR using primer pairs specific
for each target (Supplementary Table S2) and SYBR green
(LT). All data are deposited at GEO (http://www.ncbi.nlm.
nih.gov/geo/).
DNAse-seq
DNase-seq was performed on Calu-3 cells as described pre-
viously (9,29). All data are deposited at GEO (http://www.
ncbi.nlm.nih.gov/geo/).
RNA-seq
Calu-3 cells were treated with 30nM Silencer Select negative
control siRNA #2 or EHF siRNA (s25399, both from Am-
bion) using RNAiMax transfection reagent (LT). 48 h post-
transfection, RNA was isolated from five samples per treat-
ment using Trizol (LT). RNA-seq libraries were prepared
using the TruSeq RNA Sample Preparation Kit v2 per the
manufacturer’s Low-Throughput protocol (Illumina). The
libraries were sequenced on Illumina HiSeq2500 machines.
Data were analysed using TopHat and Cufflinks (30). qRT-
PCR was performed with TaqMan Reverse Transcription
reagents kit (LT), primer pairs specific for each target (Sup-
plementary Table S2) and SYBR green. All data are de-
posited at GEO (http://www.ncbi.nlm.nih.gov/geo/).
Wound repair assay
Wound closure assay was performed as previously described
(31) with modifications. Cells were treated with siRNA
as above. 72 h post-transfection, the confluent lawn was
damaged with a comb and then monitored by microscopy.
Scratch area was measured using ImageJ software.
Transepithelial resistance measurements
Calu-3 cells were grown on Transwell cell culture inserts
coated with collagen I (Sigma, C3867–1VL) and Collagen
IV (Sigma, C6745-1ML). Triplicate cultures were reverse
transfected using siRNAs described above. An epithelial
voltohmmeter (EVOM2, World Precision Instruments) was
used to take four resistivity readings (Ohms) per Transwell
every 24 h for 96 h and TER values were calculated by mul-
tiplying resistivity by the insert’s surface area (0.31 cm2).
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RESULTS
ChIP-seq identifies sites of EHF occupancy genome-wide
EHF targets in the lung epithelium are poorly character-
ized. To investigate the genome-wide binding profile of
EHF in airway epithelia, ChIP-seq was performed in Calu-
3 lung adenocarcinoma cells (24). The antibody used in the
ChIP experiments was first tested for specificity for EHF
using western blots of protein lysates from cells in which
EHF was depleted by a specific siRNA (Supplementary
Figure S1). Two independent ChIP-seq experiments were
performed. To identify EHF binding sites, the Homer soft-
ware package (28) was used to call peaks for the two sam-
ples (1537 and 5216, respectively) and ChIP input DNA
was used as a background control. Overlapping segments
of peaks called in both samples were considered high-
confidence EHF binding sites and used for further anal-
ysis. 768 binding sites were identified in both samples at
a false discovery rate (FDR) of 1% (Supplementary Table
S3). Moreover, there was significant correlation between tag
counts at peaks found in both samples (Figure 1A).
Peaks were annotated based on their genomic location.
The majority of EHF peaks were found at either intergenic
or intronic sites, as predicted for cell-type specific regulatory
elements (9,32), although many binding sites at promoters
(defined as −1 kb to +100 bp relative to the transcription
start site) were also identified (Figure 1B). De novo motif
analysis of the significant peaks seen in both ChIP-seq sam-
ples found that an Ets motif similar to the consensus bind-
ing sites for the epithelial-specific Ets transcription factor
subfamily members (EHF, Elf3 and Elf5) was significantly
enriched within these regions (P = 1e−541, Figure 1C). This
consensus sequence coincided with an EHF binding motif
characterized previously (33) and was found in 58.07% of
peaks within 50 bp of the center in the current data set. Also
enriched within EHF ChIP-seq peaks was the binding ma-
trix for the activator protein 1 (AP-1) transcription factor
complex (P = 1e−115, 1C), found in 31.25% of sites within
200 bp of the center of the peak. Sixteen percent of the peaks
contain both an EHF and AP-1 motif. This is consistent
with earlier findings that EHF binds near AP-1 motifs in
repressive contexts (12).
To validate the ChIP-seq findings, ChIP followed by
quantitative PCR (qPCR) was performed on two indepen-
dent Calu-3 chromatin samples. The sites tested included 2
intronic (in integrin, 2 (ITGA2) and 2’-5’-oligoadenylate
synthetase 3 (OAS3)), 2 intergenic (near tight junction
protein 2 (TJP2) and ArfGAP with GTPase domain,
ankyrin repeat and PH domain 1 (AGAP1)), and 2 pro-
moter sites (in Jun dimerization protein 2 (JDP2) and
phospholipase C, eta 1 (PLCH1)). These sites were chosen
due to their location near genes with a significant change
in expression following EHF depletion (ITGA2, OAS3,
JDP2, TJP2) and/or because they contained an EHF mo-
tif (AGAP1, JDP2). For comparison, one negative con-
trol (NC) region (near EHF) was selected, which lacked an
EHF ChIP-seq peak, a predicted EHF binding motif and
H3K4me1/H3K27ac enrichment. Peaks identified in ChIP-
seq were enriched over an IgG control in both replicates, at
all six sites tested, while no enrichment was seen in the neg-
ative control (Figure 1D).
Next, the EHF ChIP-seq peaks in Calu-3 cells were inter-
sected with open chromatin data for this cell line, generated
by DNase I digestion followed by deep sequencing (DNase-
seq). EHF occupancy sites showed increased DNase hyper-
sensitivity, suggesting that this factor binds to open chro-
matin (Figure 1E). To determine whether the EHF ChIP-
seq peaks contained enhancer elements, as might be pre-
dicted since many of them were intergenic or intronic, we
next performed ChIP-seq for the enhancer-specific histone
modifications H3K4me1 and H3K27ac in Calu-3 cells. Hi-
stone modification tag counts per base pair per peak were
plotted as distance from the center of EHF peaks. The
results showed a bimodal distribution of enrichment for
the H3K4me1 and H3K27ac modifications surrounding the
center of EHF ChIP-seq peaks (Figure 1F and G), which
is characteristic of enhancers and was not seen in the in-
put control. Among the 768 EHF binding sites identified
by ChIP-seq, 591 coincided with peaks of H3K27ac enrich-
ment. Sixty-four overlapped regions marked by H3K4me1,
of which 53 also showed H3K27ac enrichment. Thus,
though the majority of EHF binding sites coincide with ac-
tive histone marks, a substantial minority (166 peaks) lack
them, and these sites may contribute to EHF-mediated re-
pression of gene expression.
Annotation of EHF binding sites
Next, the nearest gene annotation method was used to pre-
dict which genes were likely regulated by occupancy of EHF
at cis-regulatory elements. This method has inherent limi-
tations since many regulatory elements lie very far from the
genes they control and can be located within introns of ir-
relevant genes. The nearest gene to each EHF binding peak
was identified and a gene ontology process enrichment anal-
ysis was performed using the Database for Annotation, Vi-
sualization and Integrated Discovery (DAVID) (34) to de-
termine the pathways that were enriched among these an-
notated genes (Figure 1H, Supplementary Table S4). Genes
located nearest to EHF binding sites were enriched for path-
ways involved in maintenance of the epithelial monolayer
and intercellular, cell–matrix and cell–substrate junctions.
An increase or decrease in EHF alters expression of genes
important for epithelial function
EHF depletion. To identify target genes regulated by EHF,
either directly or indirectly, a specific siRNA was used to
deplete EHF in Calu-3 cells (Figure 2A). Total RNA was
isolated from five negative control (NC) siRNA and five
EHF targeted siRNA samples (>90% depletion), and RNA
quality was confirmed by Nanodrop measurement of OD
260/280 and 260/230 ratios. RNA-seq was performed on
libraries generated from the 10 samples yielding ∼2.6–3.5
x107 reads per library. Gene expression values in the format
of Fragments Per Kilobase per Million mapped fragments
(FPKM) obtained from TopHat and Cufflinks (30) were
compiled into an expression value matrix. Principle compo-
nent analysis (PCA) on the FPKM values showed that the
five samples within each treatment group clustered together
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Figure 1. ChIP-seq in airway epithelial cells identifies genome-wide binding sites of EHF. (A) Comparison of tag counts between peaks identified in two
biological replicates of EHF ChIP-seq experiments. (B) Number of EHF peaks found at intergenic sites, in introns, promoters and other sites (including
exons, 5’UTRs and 3’UTRs). A total of 768 peaks were identified. Most peaks were found in either intergenic or intronic regions. (C) (Top) De novo motif
analysis shows that EHF ChIP-seq peaks are enriched for an Ets motif similar to the consensus sequence for epithelial-specific Ets transcription factor
subfamily proteins (58.07% of peaks within a 50 bp window, 82.29% within a 200 bp window) and the AP-1 binding motif (31.25% of peaks within a 200 bp
window). (Bottom) Incidence of motifs measured as distance from the center of EHF ChIP-seq peaks in base pairs (bp). (D) ChIP-qPCR validated EHF
binding to 6 peaks identified by ChIP-seq (n = 2). Peaks are labeled based on their location with the nearest gene in parentheses. An intergenic negative
control site showed no enrichment. (E) Calu-3 DNase-seq tag counts measured from the center of EHF peaks. (F) As (E) for H3K4me1 ChIP-seq. (G) As
(E) for H3K27ac ChIP-seq. (H) Gene ontology analysis by DAVID on the nearest genes to each EHF peak.
and the different treatment groups segregated along PC #2
(Supplementary Figure S2). CuffDiff (30) was used to de-
termine differentially regulated genes following EHF deple-
tion. A total of 256 genes showed a greater than 1.5-fold
difference in expression following EHF knockdown (Fig-
ure 2B, Supplementary Table S5). One hundred and twenty
one and 135 genes showed decreased or increased expres-
sion, respectively, suggesting that EHF can positively or
negatively regulate gene expression. The average distance
between EHF bound sites and EHF-activated or -repressed
genes (2930 kb and 2524 kb, respectively) was not signifi-
cantly different (P = 0.435, Supplementary Figure S3). This
observation is consistent with a role for EHF in both gene
activation and repression.
A gene ontology process enrichment analysis was per-
formed on the differentially expressed genes (DEGs) fol-
lowing EHF knockdown using DAVID (Figure 2C, Sup-
plementary Table S6). The DEGs were enriched for gene
ontology pathways crucial for lung development and repair.
Genes involved in epithelial cell differentiation and develop-
ment included frizzled class receptor 1 (FZD1), and keratins
4, 5 and 14 (KRT4, KRT5, KRT14). Pathways involved in
locomotory behavior and response to wounding were also
enriched, with DEGs including S100 calcium binding pro-
tein A8 and A9 (S100A8, S100A9), chemokine (C-X-C mo-
tif) ligands 1 and 6 (CXCL1, CXCL6) and chemokine (C-C
Motif) ligand 5 (CCL5).
Gene expression changes following EHF depletion were
validated using siRNA knockdown (KD) followed by RT-
qPCR. DEGs involved in cell–cell junctions, immune func-
tion and intracellular signaling were tested. Expression
changes seen in the RNA-seq data were replicated in
the qPCR validation (Figure 2D). ITGA2, JDP2, TJP2,
CXCL1, interleukin-8 (IL-8), dimethylarginine dimethy-
laminohydrolase 1 (DDAH1) and tight junction protein 1
(TJP1) showed changes in expression that corresponded
to RNA-seq results. The RT-qPCR and RNA-seq signals
are significantly correlated (r = 0.81, P = 0.027). ITGA2
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Figure 2. EHF depletion followed by RNA-sequencing identifies EHF as a regulator of pathways important for lung epithelial function. (A) siRNA
depletion of EHF in Calu-3 cells measured by western blot compared to -tubulin (top) and quantified using gel densitometry (bottom). (B) Relative
expression of 256 genes that showed greater than 1.5-fold change in expression following siRNA depletion of EHF. Each row represents a different gene.
(C) Gene ontology analysis by DAVID of differentially expressed genes (DEGs) with greater than 1.5-fold change in expression following EHF knockdown.
(D) EHF siRNA knockdown followed by qPCR confirmed changes in gene expression identified by RNA-seq (n = 2). All 7 genes assayed showed changes in
expression consistent with RNA-seq results. (E). Integrin, 2 protein expression significantly decreased following EHF knockdown (n = 3), corresponding
to the observed decrease in RNA abundance for this gene. * P<0.05 by an unpaired two-tailed Student’s t test, also used in Figures 4 and 5.
showed decreased expression following EHF KD, and con-
tains an EHF binding site at its promoter. To confirm that
transcriptional changes identified in the RNA-seq data were
also seen at the protein level, whole cell lysates from nega-
tive control and EHF siRNA-treated samples were analysed
by western blot to look for changes in integrin, 2 protein
levels. A specific antibody showed that integrin, 2 protein
expression significantly decreased (P<0.05) in comparison
to the -tubulin control following EHF depletion, consis-
tent with the mRNA data (Figure 2E).
EHF overexpression. A549 cell clones were generated
that stably overexpress EHF from a transfected plasmid
(pcDNA 3.1). This alveolar-like lung adenocarcinoma cell
line (35) was chosen due to its low levels of endogenous
EHF, in contrast to the high levels seen in Calu-3 cells.
Three A549 clones carrying vector only and 3 overexpress-
ing EHF were analysed further, and western blots showed ∼
11-fold more EHF protein in the latter clones (Figure 3A).
Total RNA from 3–4 replicates of each clone was isolated
and used for RNA-seq. At the transcript level (measured by
FPKM), there was an 8.6-fold increase in EHF in the over-
expressing clones. A total of 1153 genes showed a significant




















extracellular region part 2.37E-13
extracellular region 6.97E-11
plasma membrane part 4.74E-10
extracellular space 2.01E-09
plasma membrane 1.65E-08
intrinsic to plasma membrane 2.60E-08
integral to plasma membrane 2.66E-08
regulation of cell proliferation 1.38E-07
response to hormone stimulus 1.58E-07
response to wounding 1.97E-07
calcium ion binding 7.31E-07
cell proliferation 1.68E-06
urogenital system development 2.18E-06
response to endogenous stimulus 2.60E-06




Figure 3. EHF overexpression followed by RNA-sequencing confirms that
EHF controls genes integral to airway epithelial function. (A). Western
blot probed with an antibody to EHF shows low levels of EHF in A549
cell clones containing the pcDNA 3.1 vector alone (pcDNA clones) and
higher levels in clones expressing pcDNA-EHF (EHF clones). -tubulin
provided the loading control. (B) Relative expression of 1153 genes that
showed greater than 1.5-fold change in expression in EHF overexpressing
clones versus control clones. Each row represents a different gene. (C) Gene
ontology analysis by DAVID of DEGs with greater than 1.5-fold change
in expression in EHF overexpressing clones.
change in expression of >1.5-fold in the EHF overexpress-
ing clones as compared to the vector clones (Figure 3B, Sup-
plementary Table S7), with 761 increasing and 392 decreas-
ing. These data confirm that EHF can positively or nega-
tively regulate gene expression.
A gene ontology process enrichment analysis was per-
formed on the DEGs using DAVID (Figure 3C, Supple-
mentary Table S8). These genes were enriched for path-
ways involved in extracellular matrix properties, plasma
membrane structure and function, cell proliferation and
response to wounding. Genes involved in the extracellu-
lar region include multiple collagens (COL4A3, COL5A1,
COL5A2, COL7A1 and COL12A1), mucins (MUC1,
MUC3A, MUC5AC and MUC13) interleukins (IL6, IL11
and IL15) and members of the tumor necrosis factor (lig-
and) superfamily (TNFSF9, TNFSF15 and TNFSF13).
Transcripts related to the plasma membrane include matrix
metallopeptidase 14 (MMP14), CD44 and multiple solute
carrier family members relevant to lung epithelial function
(SLC6A14, SLC7A2, SLC7A7, SLC12A2, SLC16A7 and
SLC23A2). Moreover, SLC6A14 is a pleiotropic gene mod-
ifier of lung disease severity and age of first Pseudomonas
aeruginosa infection in CF patients (36). These genes and
pathways are critical for response to the environment, main-
tenance of the epithelial barrier and extracellular matrix
production.
Common targets of EHF modulation across cell types.
Fifty-eight genes were positively regulated in both Calu-3
and A549 cells (that is, expression decreased in EHF de-
pleted Calu-3 cells and increased in EHF-overexpressing
A549 clones, Supplementary Table S9). A gene ontology en-
richment analysis showed that these 58 genes were associ-
ated with processes of epithelial differentiation, anchoring
junction and regulation of cell proliferation (Supplemen-
tary Table S10). Furthermore, 28 genes were negatively reg-
ulated in both cell types, many of which encode cell surface
proteins (Supplementary Table S11).
EHF depletion slows the rate of wound repair in Calu-3 cells
Our RNA-seq data suggest that EHF is important in ep-
ithelial barrier integrity and regulates genes important for
cell motility, which are essential components of wound re-
pair. Shortly after epithelial injury, nearby epithelial cells
migrate to repopulate the damaged area (37), a process that
can be monitored in vitro using a wound scratch assay (31).
To determine the effect of EHF depletion on wound repair
in airway epithelial cells, a wound scratch assay was per-
formed in Calu-3 cells. Cells were transfected with NC or
EHF siRNA and grown to confluence. 72 h after transfec-
tion, the cell monolayer was wounded in a uniform manner
using a comb. Scratches were then imaged at 3, 6, 9 and 12
h after transfection (Figure 4A). At 3 h, the average diame-
ter for negative controls was 0.60 mm2 and the average for
EHF siRNA is 0.53 mm2. These values are not significantly
different (P = 0.25). Cells were grown for 27 h post-scratch
to ensure wound closure and then lysed to measure EHF
depletion. A comparison of the migration rate between NC
and EHF siRNA-treated cells shows that the latter migrated
at 67% the rate of NC treated cells at 6 h (P<0.01) and 71%
13594 Nucleic Acids Research, 2014, Vol. 42, No. 22
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Figure 4. Effect of EHF depletion on wound repair in Calu-3 cells. (A)
Images of negative control (NC) and EHF siRNA treated cells at 3, 6, 9 and
12 h after wounding. The outline of the wound is traced with a gray line.
(B) Depletion of EHF significantly reduced the rate of wound closure at 6
and 9 h after wounding (n = 3). This difference was no longer evident 12 h
after wounding. **P<0.01, ***P<0.001. (C) siRNA knockdown of EHF
was measured by western blot in lysates taken 27 h after wounding and the
signal was quantified using densitometry. EHF depletion was maintained
throughout the experiment.
at 9 h (P<0.001) (Figure 4B). This difference was no longer
apparent at 12 hours. Western blots of cell lysates probed
with an antibody specific for EHF and a -tubulin con-
trol antibody showed that EHF depletion was maintained
throughout the wound repair assay; 27 h after wounding,
EHF protein levels were 15% of those in negative control
treated cells (Figure 4C).
Transepithelial resistance is increased following depletion of
EHF in Calu-3 cells
Experimental modulation of EHF shows that this factor
regulates genes encoding proteins that establish and main-
tain intercellular junctions. Tight junctions are critical for
preserving a selectively permeable barrier between the lu-
minal and basolateral surfaces of the intact epithelium.
These barrier functions are monitored by transepithelial re-
sistance (TER) measurements of cells grown in vitro on per-
meable supports. TER measurements were performed on
post-confluent Calu-3 cells to investigate the effect of EHF
depletion on epithelial cell monolayer and tight-junction
formation. Calu-3 cells were seeded onto collagen coated
Transwell inserts and reverse transfected with either NC or
EHF siRNA in triplicate. Resistivity measurements were
taken from each insert in quadruplicate at 24, 48, 72 and 96
h post-transfection and TER values were calculated. EHF
depleted Calu-3 cells showed higher TER compared to the
negative control cells at multiple timepoints (Figure 5A).
Normalization across 3 independent experiments revealed
that TER values were significantly higher in EHF-depleted
Calu-3 than controls at 48 h (P<0.05), 72 h (P<0.001)
and 96 h (P<0.0001) (Figure 5B). Cells were lysed at 96 h
and EHF/-tubulin western blots confirmed EHF siRNA
knockdown (Figure 5C).
DISCUSSION
Understanding regulation of gene expression in lung ep-
ithelial cells is critical to determining how these cell types
develop, differentiate and respond to the environment. In-
tegration of these individual processes is required for nor-
mal airway function and their perturbation results in airway
pathology. Several transcription factors are known to have
an important role in lung epithelial development and func-
tion, including FOXA1/A2 (38), SOX family members (39)
and Grainyhead (40), among others. Here, we characterize
the role of EHF in coordinating gene expression profiles in
lung epithelial cells. Our studies show that this transcription
factor regulates genes and pathways involved in maintain-
ing epithelial cell identity.
Previous studies on the function of EHF focused on its
role at gene promoters, where it was shown to act as ei-
ther a gene activator or repressor depending on the cellu-
lar context (12,15,16,18). However, the majority of EHF
binding sites identified here by ChIP-seq were either in-
tronic or intergenic. This is consistent with our data show-
ing that cell-type selective open chromatin in primary air-
way epithelial cells is predominantly located outside gene
promoters (9). The observation that EHF binding sites were
enriched for H3K4me1 and H3K27ac histone modifica-
tions further reinforces the prediction that this transcrip-
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Figure 5. Effect of EHF depletion on transepithelial resistance in Calu-3
cells. (A) TER measurements in a single experiment show that EHF de-
pleted Calu-3 cells (EHF siRNA, gray) had higher TER values compared
to negative control cells (NC siRNA, black) at 48 to 96 h post-transfection.
(B) TER measurements EHF siRNA normalized to NC; EHF depletion
resulted in a significantly higher TER than NC-treated cells at 48 (*P<
0.05), 72 (***P<0.001) and 96 h (****P<0.0001) (n = 3). (C.) Western
blot shows NC and EHF siRNA transfected Calu-3 cells from a single
TER experiment (in triplicate) lysed at 96 h and depletion of EHF protein
relative to -tubulin was confirmed.
tion factor binds to distal elements to regulate gene expres-
sion. H3K4me1 is a general marker for enhancers, whereas
H3K27ac tends to mark active regulatory elements (41,42).
Moreover, EHF ChIP-seq peaks in Calu-3 cells also showed
increased DNase I hypersensitivity when compared to back-
ground, suggesting that the factor binds to nucleosome-
depleted regions in these cells. Thus, EHF binds to active
enhancers, promoters and potentially other cis-regulatory
elements in open chromatin sites to orchestrate its transcrip-
tional program.
EHF ChIP-seq peaks are enriched for AP-1 binding sites,
suggesting that members of this complex (which includes
heterodimers of the c-Fos, c-Jun, ATF and JDP families)
may be interacting partners of EHF in regulating gene ex-
pression. This prediction is consistent with a previous study
showing that EHF represses promoters containing AP-1
binding motifs (12). In general, promoters containing AP-
1 sites are responsive to mitogen-activated protein (MAP)-
kinase signaling, which plays an important role in a diverse
array of cell processes including differentiation, prolifera-
tion and migration. AP-1 and Ets family members have
been shown to interact directly in vitro and in activated T-
cells (43) and to co-localize in genome-wide ChIP-seq stud-
ies in prostate cancer cell lines (44). The extrapolation from
our data that AP-1 and EHF may interact directly genome-
wide to regulate gene expression in the lung epithelium
warrants further study. Moreover, the mechanism whereby
these factors could co-regulate gene expression through cis-
regulatory elements and promoters is intriguing.
We found that EHF bound to 768 high-confidence sites
in human lung epithelial cells, which was less than the num-
ber seen in EHF ChIP-seq performed in the mouse cornea
epithelium (17). However, the previous study used a higher
FDR (5%) to call peaks in comparison to the 1% used in our
analysis. Moreover, we reduced the number of sites signifi-
cantly by only considering peaks that overlapped in two in-
dependent experiments (1537 and 5216 peaks, respectively),
while the former analysis did not require peaks to be present
in two biological replicates.
We showed that depletion of EHF in Calu-3 cells al-
tered the expression of genes in pathways that are important
for epithelial and ectoderm development, and response to
wounding. EHF overexpression in A549 cells differentially
regulated genes involved in response to wounding and cell
proliferation. The EHF depletion and overexpression ex-
periments were performed in different cell types (with high
or low endogenous EHF levels, respectively) to facilitate
the greatest expression changes. Thus, under baseline condi-
tions many EHF-regulated genes may differ between them.
Despite this, many genes were similarly regulated in both
cell types. EHF positively regulated genes involved in ep-
ithelial differentiation and cell junctions in both cell types.
Our data correlate well with the reported effects of EHF
knockdown in corneal epithelium (17). Although the spe-
cialized biological properties of the airway and eye epithe-
lium are different, they share common features of all ep-
ithelial layers in the body. EHF depletion in immortalized
prostate epithelial cells caused up-regulation of genes in-
volved in epithelial-mesenchymal transition (18), suggest-
ing that one important property of this transcription fac-
tor is the maintenance of epithelial phenotype. The mech-
anism whereby EHF coordinates its transcriptional targets
to achieve this is of interest, since the factor is known to
be either an activator or repressor of gene expression. Our
data show that though EHF occupies the promoter of some
DEGs identified by RNA-seq after EHF-depletion, many
lacked an EHF binding site at their promoter. However,
the predominance of EHF ChIP-seq peaks in intronic and
intergenic regions rather than promoters suggests that the
majority of DEGs may be controlled through distal EHF-
regulated cis-elements. It is also likely that some genes are
indirect targets of EHF.
Of the genes tested to validate the RNA-seq results,
DDAH1 showed the greatest change in expression following
EHF depletion. DDAH1 metabolizes asymmetric dimethy-
larginine (ADMA) a competitive inhibitor of nitric ox-
ide synthase (NOS). ADMA potentiates lung inflamma-
tion in a mouse model of allergic asthma (45). Further-
more, DDAH1 overexpression attenuates airway inflamma-
tion in a different mouse model of asthma by decreasing
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IgE expression and eosinophil migration in the lung. It also
causes a decrease in expression of genes encoding cytokines,
chemokines and matrix metalloproteinases (46). Since EHF
apparently represses DDAH1 in our studies, this suggests a
role for the transcription factor in potentiating allergic lung
inflammation.
In Calu-3 cells, EHF regulated several genes critical for
normal cell motility and wound repair, including ITGA2,
S100A8 and S100A9. Integrin, 2, which decreases follow-
ing EHF depletion, contributes to alveolar epithelial cell
migration on collagens I and IV (47,48). We found that
wound closure was impaired upon EHF knockdown, con-
sistent with down-regulation of genes that promote cell
motility. This phenotype may be due to changes in ITGA2
or other genes involved in cell motility or proliferation.
Among genes comprising the GO:0009611 response to
wounding pathway, 14 are differentially expressed after
EHF depletion, including a number of chemokines (Supple-
mentary Table S6). Furthermore, 60 were differentially ex-
pressed in response to EHF overexpression (Supplementary
Table S8). This suggests that EHF regulates wound heal-
ing across multiple lung epithelial cell types. Three genes
showing altered expression after EHF depletion in Calu-
3 cells, CXCL1, CXCL6 and CCL5, encode chemokines
expressed in bronchial epithelium. Their release is in-
creased in response to inflammatory mediators (49,50),
and while CXCL1 and CXCL6 are neutrophil chemoat-
tractants, CCL5 mobilizes monocytes, T cells, basophils
and eosinophils. Inflammation is an integral part of the
response to wounding and determines, in part, whether a
damaged epithelium undergoes proper repair or fibrosis
(51). CXCL1 is over-expressed in fibrotic versus non-fibrotic
lungs (52). CXCL6 expression is increased in patients with
idiopathic fibrosis, and its inactivation can attenuate in-
flammation and fibrosis in the bleomycin mouse lung fi-
brosis model (53). IL-6 and IL-11 showed increased expres-
sion in EHF-overexpressing clones as compared with con-
trol clones. Overexpression of these cytokines in the mouse
lung leads to structural changes and altered responsiveness
to methacholine in the airway (54). Our results show that
EHF regulates all of these inflammatory mediators, which
could directly contribute to inflammation and fibrosis dur-
ing wound repair. The impact of EHF in the wound scratch
assay supports a general role in controlling response to ep-
ithelial damage. Of particular relevance to the role of ge-
netic elements at 11p13 in modifying CF lung disease sever-
ity, aberrant wound repair is integral to the pathology of
lung disease, including CF, in which cell migration is im-
paired (55). Therefore, this might be one of the mechanisms
by which EHF contributes to dysfunction in this tissue.
Our ChIP-seq results show that EHF binds near genes in-
volved in cell–cell and cell–substrate/matrix junctions, sug-
gesting that this factor has an important role in maintaining
the epithelial cell barrier. This was confirmed by measure-
ments of transepithelial resistance in post-confluent Calu-3
monolayers, which showed that EHF depletion increased
TER. Maintenance of the epithelial barrier is critical for
normal lung function and abnormal intercellular adhesion
is linked to lung disease and infection (2). Moreover, a re-
duction in TER is associated with the F508del mutation in
cell culture models of CF airway epithelia (56). Coordina-
tion of expression of genes that encode components of junc-
tional complexes may be a mechanism whereby EHF regu-
lates barrier function of the lung epithelium. This capabil-
ity of EHF is equally relevant to the potential mechanisms
whereby genes at 11p13 contribute to disease severity in the
CF lung. Since EHF regulates pathways of inflammation,
motility and barrier function, it may be pivotal in coordi-
nating processes involved in lung epithelial repair.
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